Insider · CIK 0001911047
Forbion Growth Opportunities Fund I Cooperatief U.A.
Files at NAMS (NewAmsterdam Pharma Co N.V.), ENGN (enGene Holdings Inc.). First filing Oct 18, 2024, latest Nov 1, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ENGN: enGene Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | ENGNbuy enGene Holdings Inc. | $5.0M 561,797 shares | +23% | - | |
| 38Weak | ENGNbuy enGene Holdings Inc. | $3.0M 470,633 shares | +24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +561,797 | $8.90 | $5.0M | 3,032,430 | Nov 1, 2024 |
| Dec 27, 2023 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +2,750 | $7.17 | $20k | 2,002,750 | Oct 18, 2024 |
| Dec 28, 2023 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +5,050 | $7.69 | $39k | 2,007,800 | Oct 18, 2024 |
| Dec 29, 2023 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +400 | $8.30 | $3,320 | 2,008,200 | Oct 18, 2024 |
| Dec 29, 2023 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +9,620 | $9.09 | $87k | 2,017,820 | Oct 18, 2024 |
| Sep 27, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +38,396 | $5.94 | $228k | 2,056,216 | Oct 18, 2024 |
| Sep 27, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +3,243 | $6.38 | $21k | 2,059,459 | Oct 18, 2024 |
| Sep 30, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +341,332 | $6.34 | $2.2M | 2,400,791 | Oct 18, 2024 |
| Oct 1, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +35,279 | $6.44 | $227k | 2,436,070 | Oct 18, 2024 |
| Oct 2, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +10,153 | $6.37 | $65k | 2,446,223 | Oct 18, 2024 |
| Oct 3, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +5,769 | $6.48 | $37k | 2,451,992 | Oct 18, 2024 |
| Oct 4, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +5,997 | $6.54 | $39k | 2,457,989 | Oct 18, 2024 |
| Oct 7, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +11,844 | $6.55 | $78k | 2,469,833 | Oct 18, 2024 |
| Oct 8, 2024 | ENGN enGene Holdings Inc. | POpen-market purchase Common Shares | +800 | $6.60 | $5,278 | 2,470,633 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.